While it has been suggested that the transcription factor, interferon regulatory factor 4 (IRF4), is involved in the MDP-NOD2-induced insulin sensitizing effects during obesity, the precise mechanism of MDP’s beneficial effects has yet to be elucidated. This evidence concerns the gene IRF4 and obesity due to melanocortin 4 receptor deficiency.